TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Expression of TAS2-Receptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in social and emotional life skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Peer social behaviour
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: diversity of bacterial species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abundance of bacterial species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caries risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of adalimumab-680LT
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of violence suffered by transgender women
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Skin bacterial burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Social Connectedness Scale SCS-R
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: WHOQOL-HIV Bref
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: WHOQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: rate of return to sport
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nutritional indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Muscle Elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in metabolic health risk indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in cardiovascular health risk indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left Ventricular Filling Pressure Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Response of treated target lesion(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number and percentage of participants with adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of participants with adverse events of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: Positive predictive value (PPV) of 68Ga-FAPI46 PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: lung cancer screening intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lung cancer screening knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Blood level of the immunosuppressive drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Validity of TQoR-15 questionnaire (24 hours)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Validity of TQoR-15 questionnaire (72 hours)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EMG activity of the thenar muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG activity of the hypothenar muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Nerve conduction velocity of the ulnar nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in locoregional failure (LRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: effective preparation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: taste score evaluated by patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Body composition measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hormonal analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of composite clinical benefit endpoints
Endpoint domain: Mortality/survival
Primary endpoint: Knowledge Level Evaluation Regarding Stoma Care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stoma Care Skill Grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student Satisfaction and Self-Confidence in Learning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Inhibitor Formation
Endpoint domain: Adverse events/effects
Primary endpoint: Change in magnitude of negative and positive valence adjectives
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brain activation measured by functional magnetic resonance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in disease activity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in health-related quality of life (HRQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of complete histopathologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Compliance with screening protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of screening protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Bacteria concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Daily symptoms score (DSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Change in the Ability to Implement COVID-19 Health Guidelines
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean Change in COVID-19 Knowledge Among Faith-based Leaders
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total Number of Older Adult Parishioners Who Received at Least One COVID-19 Vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy on a phonological STM task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI measures of language network activation after tACS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Endotoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frailty Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calf and mid-upper arm circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitochondrial respiration on adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of stool sample acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Creatine kinase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in blood lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neurotracker scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the implant system
Endpoint domain: Adverse events/effects
Primary endpoint: Ultrasound Skill Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emergence behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in misophonia impairment and severity using a composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin conductance level (scl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Subjective Units of Distress (SUDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical Activity Hours Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedentary Behavior Hours Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain at TMJ during spontaneous mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck flexor muscle endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck extensor muscle endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scapular stabiliser endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tDCS Headgear Location
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step Difficulty Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Responses to Comfort Survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Multiple symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upstroke time (TMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in BOLD-signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depleted mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Passive suicidal ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Suicidal urges
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first occurrence of Major Adverse Cardiovascular Events (MACE+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cold pain sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: electrical pain sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of treatment emergent adverse events (TEAEs)/serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence on overall safety
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptable maximum tolerated dose for participants
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy limits for pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy limits for oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy limits for respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy limits for temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromuscular blockade recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with target lesion failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: prevalence of anxiety-depressive disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Immediate adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited local and systemic signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Cancellation rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intraoperative events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of intraoperative and post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: IFN-I score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in plasma concentration of c-cistatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: long term fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Pharmacokinetics of Fexuprazan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacodynamics of Fexuprazan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprematurity respiratory disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain (Visual analogue scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder pain disability index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Active range of movement of the shoulder joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Levels of VKDP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial Vaginosis Recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Uterine niche symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hystroscopic findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: US findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical remission based on PCDAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intra-cluster variance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder, knee and ankle injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of thrombotic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived Changes in Sleep Quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Perceived Changes in Sleep Quantity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Perceived Changes in Sleep Habits
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Correlation coefficient between iron load in MRI and age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in menstrual cycle regularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Changes in severity of menstrual cramps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Changes in hormonal skin issues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in excessive body hair or facial hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incidence of Advanced-Stage Tubo-Ovarian or Primary Peritoneal Carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Major Adverse Cardiovascular and Neurologic Events (MACNE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of Cardiovascular Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Total rate of Heart Failure Hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change scores over two weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titers (GMTs) against influenza vaccine antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with seroconversion for influenza vaccine antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Short-term outcome of neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary score (KCCQ-CSS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of subjects achieving ACR50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative reduction in liver fat content of at least 30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in automated office blood pressure (AOBP) systolic blood pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of composite endpoint of asymptomatic DVT, confirmed symptomatic DVT, non-fatal PE and all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of composite endpoint of major and clinically relevant non-major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with unbound bilirubin (UB) concentration greater than 40 nM/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average unbound bilirubin (UB) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients with a prolonged brain stem auditory-evoked response (BAER) V latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Composite Primary Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular Surface Disease Index (OSDI) overall treatment effect
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Symptom Assessment iN Dry Eye (SANDE) overall treatment effect
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fluorescein Break-up time (FBUT) overall treatment effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Olfactory responses measured by TDI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative recurrence of renal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Distress Tolerance Scale (DTS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma concentrations of IL-6, IL-10 and TNF-α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients with successful measurement of probe drug MR (Metabolic ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-Efficacy in Labor
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Edinburgh Postpartum Depression Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Symptoms of post traumatic stretch disorder
Endpoint domain: Adverse events/effects
Primary endpoint: Hemophilia Joint Health Score (HJHS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local/systemic solicited adverse reactions/events
Endpoint domain: Adverse events/effects
Primary endpoint: mobility, in particular the risk of falling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Somato-vegetative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall subject complete response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous Carbon Dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incisional hernia occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Functional Motor capacity of the upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Motor deficit of the upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hand dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Bacterial Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Peripheral Blood Dipeptidylpeptidase IV (CD26)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants who Complete the Study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Program Satisfaction Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants who Complete all Training Videos by Week 2
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Instrumented Gait Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowest On-treatment Prostate Specific Antigen (PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete Metabolic Response (CMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient Pain Levels in the Post-Operative Period
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in Post-Operative Opioid Use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Occurrence of MRI-related event for CIED
Endpoint domain: Adverse events/effects
Primary endpoint: Mediolateral instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete 10 reps of lifting/lowering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes